Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials
Titel:
Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials
Auteur:
Lipton*, A. Stopeck, A. von Moos, R. Henry, D. Richardson, G. Rodriguez, G. Bourgeois, H. Ke, C. Jun, S. Dansey, R.